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survival data were extracted from a sample of members
enrolled in a large Health Maintenance Organization.
Study subjects were deﬁned as persons aged >40y who,
between 1995 and 2000, had at least 2 visits to a physi-
cian or one hospital admission with a diagnosis of COPD
and at least 90 days exposure to LABA and/or ICS. Cat-
egories of costs captured included medications, physician
visits, and hospitalizations. Survival was estimated using
a parametric regression model. Costs were adjusted for
censoring and known prognostic factors, including demo-
graphic variables and measures of disease severity. A cost-
effectiveness analysis was conducted from a third party
payer perspective over a time horizon of 36 months.
RESULTS: The estimated average survival and costs
were: 2.4 life years (LY) (CI: 2.3; 2.5) and $43,900 (95%
CI: $38,600; $51,800) for not receiving ICS or LABA; 2.7
LY (CI: 2.6; 2.8) and $36,750 (CI: $29,370; $43,800) 
for ICS alone; 2.7 LY (CI: 2.6; 2.8) and $44,900 (CI:
$38,700; $51,840) for LABA alone; and, 2.8 LY (CI: 2.7;
2.9) and $43,250 (CI: $36,530; $56,900) for subjects
treated with both ICS and LABA. The most favorable
treatment options were ICS and the combination ICS +
LABA. CONCLUSIONS: There is an acute need to ﬁnd
cost-effective treatments for persons with COPD. ICS and
LABA are currently being tested in randomized trials. 
If the impact on survival compares to that shown in
observational studies, those therapies are likely to be cost-
effective in the United States.
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ASSESSMENT OF THE IMPROVEMENTS IN
QUALITY OF LIFE POST-LUNG TRANSPLANT:
A COMPARISON OF RECIPIENTS VERSUS
CANDIDATES
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OBJECTIVES: Lung transplant is increasingly becoming
the choice of therapy for several end-stage pulmonary
conditions. Factors critical to making decisions for a lung
transplant revolve around transplant costs and improve-
ments in health-related quality of life (HRQL) post-
transplant. The primary objectives of this study are: a) 
To compare the HRQL of transplant recipients versus
candidates; and b) To compare recipients versus candi-
dates on utilities derived using two methodologies by
Nichol et al. (2001) and Brazier et al. (2002).
METHODS: A survey questionnaire was mailed to 145
lung or heart-lung transplant recipients and 99 candidates
awaiting lung transplant at a major University hospital in
the Midwestern USA. The questionnaire comprised of
instruments such as the SF-36, Center for Epidemiologic
Studies Depression (CES-D) Scale, Symptom Distress
Scale (SDS), Illness Intrusion Rating Scale (IIRS), Pul-
monary Scale (PS), Dyspnea Scale (DS), and Health Status
(VAS). T-tests were employed to analyze differences
between the two groups on the HRQL measures.
RESULTS: There were a total of 166 respondents (99
recipients and 67 candidates). Recipients had signiﬁcantly
higher SF-36 PCS scores (39.97 vs. 25.56, p = 0.001) and
VAS scores (73.30 vs. 49.24, p = 0.001) as compared to
the candidates. No signiﬁcant differences were observed
between the 2 groups on the SF-36 MCS and CES-D
scores. Recipients demonstrated signiﬁcantly lower levels
of dyspnea, pulmonary distress, and illness intrusion in
comparison to transplant candidates. Both the method-
ologies for deriving utilities from the SF-36 yielded higher
scores for recipients versus the candidates; Nichol utili-
ties (0.76 vs. 0.69, p = 0.001) and Brazier utilities (0.70
vs. 0.63, p = 0.001). CONCLUSIONS: It was observed
that in general recipients had signiﬁcant improvements in
physical health as compared to candidates. The incre-
mental beneﬁt in terms of utilities would be larger when
calculated using the Nichol methodology, despite both
methodologies being based on the SF-36 and standard
gamble. Further research needs focus on the validity of
these utilities for purposes of a cost-utility analysis.
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HRQoL is an important outcome measure for chronic
childhood diseases. However, it is infrequently used in
Asia due to the difﬁculty of obtaining appropriately trans-
lated and culturally adapted instruments. We adapted the
Childhood Asthma Questionnaires C (CAQ-C) previ-
ously used in UK and Australia in children aged 11 to 16
years old. OBJECTIVES: To culturally adapt and validate
a disease speciﬁc HRQoL questionnaire, CAQ-C for
childhood asthma in Singapore. METHODS: CAQ-C
was adapted after pre-testing in asthmatic children.
Changes to the UK and Australia versions were made to
reﬂect the Singapore educational system, culture, lan-
guage and climate. A cross-sectional validation was con-
ducted. All consenting asthmatic patients aged 11 years
and above attending the Specialist Respiratory Clinic in
KK Women’s and Children’s Hospital participated.
Patients with other co-morbidities that could signiﬁcantly
affect their HRQoL were excluded. RESULTS: The
adapted CAQ-C was validated in 99 patients (41 females
and 58 males) with a mean age of 12.84 °Ó1.64 years
(range: 10–17 years). More than three quarters completed
the questionnaire in 10 minutes or less. The Severity (12
items), Distress (11 items) and Active Quality of Living
(4 items) scales had similar internal consistency as the UK
and Australian versions (Cronbach’s a = 0.71–0.85). Our
Teenage Quality of Living scale had only 3 items but
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obtained a Cronbach’s a value of 0.62 which is compa-
rable to other versions. The Reactivity scale also had 3
items but its Cronbach’s a value was only 0.25. CON-
CLUSIONS: Childhood Asthma Questionnaire (CAQ-C)
is a simple and acceptable HRQoL instrument for asth-
matic teenagers. Most found the questionnaire easy and
fast to complete. The adapted version has Distress, Sever-
ity, Teenage and Active Quality of Living scales with good
internal consistency. However, further investigations are
needed to determine the internal structure of the scales 
by factor analysis and improve the Reactivity scale 
reliability.
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REVIEW OF QUALITY OF LIFE INSTRUMENTS
IN PEDIATRIC ASTHMA
Yu AP, Nichol MB, Globe D
University of Southern California, Los Angeles, CA, USA
OBJECTIVES: Health status is an important outcome
measure in assessing treatment of asthmatic children.
However, measuring quality of life in asthmatic children
is difﬁcult, requiring measures that are both sensitive to
asthma and appropriate for children. This review sum-
marizes and evaluates published quality of life instru-
ments for pediatric asthma. METHODS: Articles were
obtained by searching the Medline up to date. The fol-
lowing ﬁelds were extracted from articles for each instru-
ment and summarized in a table: applicable age group,
type of respondent, means of administration, items and
domains, scaling, item selection, psychometric properties
and versions in foreign languages. Standard psychomet-
ric measures including internal consistency and test-retest
reliability, validity and responsiveness were chosen as
evaluation criteria. Alpha 0.7–0.9 was chosen as accept-
able range for reliability. RESULTS: 10 asthma- and 
children-speciﬁc instruments were identiﬁed (ASDQ,
AMA, CAQ, CHSA, FSI, HAY, ITG-CASF, LAQCA,
AAQOL, PAQLQ), in addition to three generic instru-
ments applied in pediatric asthma. These instruments
vary widely in age groups, length, items and domains,
means of administration, psychometric measures, and
versions and languages. The number of items ranges from
6–71, and number of domains 1–7. All instruments
contain physical symptoms or activities domains. All
measured internal consistency; only CAQ had domains
with alpha lower than the minimum requirement. ASDQ,
AMA, FSI and ITG-CASF had no test-retest reliability
reported, and HAY and CHSA had domains with low
reproducibility with alpha less than 0.7. Only HAY and
PAQLQ demonstrated good responsiveness by showing
changes in scores associated with clinical change. PAQLQ
is the only instrument satisfying all selected criteria.
CONCLUSIONS: Responsiveness to change is critical in
quality of life outcomes studies, yet many instruments did
not report this measure and therefore need further vali-
dation. Among 10 selected instruments, only PAQLQ sat-
isﬁed the selected criteria and is recommended to use for
ages 7–17.
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META-ANALYSIS OF THE EFFECTIVENESS 
OF MAMMOGRAPHY
Zammit DC, Hay JW
University of Southern California, Los Angeles, CA, USA
The efﬁcacy of mammographic screening in the reduction
of breast cancer (BC) mortality is controversial. OBJEC-
TIVE: To compare the results obtained by using only
“unbiased” trials in a meta-analysis, to what is obtained
when considering also all the trials that were previously
excluded, and to conduct a meta-analysis of the efﬁcacy
of mammographic screening, including data from all
sources (8 trials) and adjusting for qualitative bias.
METHODS: Fixed effects (FE) and random effects (RE)
inverse-variance weighted techniques were used to obtain
the pooled relative risk (RR) of death from BC in screened
groups vs. control groups. The pooled RR was also esti-
mated for all-cause mortality. Heterogeneity testing was
done for every set of studies pooled. Sensitivity analysis
to model choice and to inclusion criteria was carried out.
2. Quality measures were assigned to each trial, to
account for biases in design, intervention, patient follow-
up, outcome measurement and statistical analysis.
Quality-weighted RE analysis combined all 8 trials to esti-
mate the RR of BC mortality in screened groups vs.
control groups, in women of all ages. The analysis was
repeated in two age subgroups: women under 50, and
over 50. Cumulative and sensitivity analyses tested the
inclusion criteria and the quality weighting method.
RESULTS: Pooling all the trials for women at any age
showed screening to cause a signiﬁcant 20% reduction in
BC mortality, with a RE RR of 0.796(95% CI =
0.69–0.91). All-cause mortality was not signiﬁcant [RR =
0.99(95% CI = 0.94–1.04)]. Sensitivity analysis did not
change the estimates much. Quality-weighted analysis
resulted in RR of 0.84(95% CI = 0.73–0.96), 0.89(95%
CI = 0.74–1.09) and 0.81(95% CI = 0.71–0.92) in women
of all ages, under 50 and over 50, respectively. CON-
CLUSIONS: Mammography reduced breast cancer mor-
tality rates among women 40–74 years of age, with
greater risk reduction observed among older women. The
efﬁcacy of mammographic screening in the 40–49 age
group remains in question.
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A MULTIDIMENSIONAL ANALYSIS OF 
DELIVERY-CARE
Panella M, Marchisio S
University of Eastern Piedmont “A. Avogadro”, Novara, Italy
OBJECTIVES: To evaluate effectiveness, costs and cus-
tomers’ satisfaction of delivery care in the Obstetrics Divi-
sion of the Hospital of Novara (Italy). METHODS: We
